Excipients present a challenge for oral drug bioavailability and it is recognized that excipient variability needs to be implemented in Quality by Design (QbD) approaches. The purpose of this thesis was to identify the biopharmaceutical implications of excipient variability on p…
"3" Result
Sort By:
Over recent years the delivery of nanosized drug particles has shown potential in improving bioavailability. Drug nanosizing is achieved by 'top-down' and by 'bottom-up' approaches. Owing to limitations associated with the top-down techniques, such as high energy input, electros…